Fig. 5From: A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinomaExpression of immune checkpoint molecules between the two risk groups in the TCGA training cohort and GEO validation cohort. A, E PD-1. B, F CD274. C, G PDCD1LG2. D, H CTLA4Back to article page